BCL2 and diffuse large B-cell lymphoma: Studies have shown that MLN4924 can effectively inhibit NAE activity in DLBCL cells, resulting in a decrease in the level of CRL and an increase in the content of BCL-2 protein, and then induce the apoptosis of DLBCL cells (Torka et al., 2020).